Gate2Brain

🚀 Gate2Brain is Virtually Partnering at #RESIBOSTON! 🚀 After winning the IPC challenge pitch at RESI BCN, here we are! Discover our groundbreaking technology for delivering therapeutics across biological barriers! Our innovative platform is primed for R&D collaborations and out-licensing opportunities. If you're looking to invest in cutting-edge solutions, let’s connect! 📌 Don’t miss this opportunity! Schedule a meeting with us now: RESI Partnering Platform: https://lnkd.in/gEecZet5 Let’s unlock the future of therapeutic delivery together! 💡 #Biotech #Pharma #Innovation  #Investment #RESIBOSTON #Partnerships

Just before heading off for the holidays at the end of July, the Gate2Brain family came together for our summer Retreat 2024 🌞✨. Held for the third consecutive year at what we now consider our rural headquarters 🏡, Santes Creus, this retreat offered us the perfect opportunity to reflect on the past four years, address upcoming challenges and objectives 🧗♀️, and, most importantly, reconnect with ourselves and our colleagues 🤝💡. Over the course of two intense days, we balanced recreational and work activities ⚖️, engaging in enriching discussions 🗣️, learning experiences 📚, and meaningful connections 🤗. The outcome of the retreat was overwhelmingly positive ✅. Sharing our achievements 🏆 and challenges 🛠️ with the Gate2Brain family, listening to their insights 👂, exchanging knowledge 💭, and enjoying time together 😄 proved to be incredibly rewarding. While finding joy in our work is fulfilling, the true pleasure comes from collaborating with such remarkable colleagues 👏, making this journey all the more special 🌟. And because a picture is worth a thousand words 📸, here are a few snapshots from our summer retreat.

We’ve had a busy end of August at Gate2Brain, attending two major peptide conferences—the Peptide Therapeutics Forum 2024 and the European Peptide Symposium in Florence—where our CEO, Meritxell Teixido, took the stage to share insights on our latest advancements. We were also thrilled to hear from Nobel Laureate Morten Meldal and celebrate the incredible achievements of Professors Fernando Albericio and David Andreu at the Josef Rudinger Memorial Award ceremony. These moments were particularly special for us, as both professors have been instrumental in our journey. Discover more about these events and our exclusive interview with Fernando Albericio, Gate2Brain's External Advisory Board Member, in our latest newsletter! #PeptideScience #Innovation #Gate2Brain #AdvisoryBoard #Research #MedicinesBeyondBarriers

Breaking Barriers in Science 🚧: The Journey of Meritxell Teixido and Gate2Brain Interview by Caitlin Dolegowski Following our participation in RESI Europe and our first-place finish at RESI Europe’s Innovator’s Pitch Challenge (IPC), Life Science Nation sat down with us to learn more about our work. 🗣️In this interview our CEO, Meritxell Teixido, shares her vision for Gate2Brain, a biotech company committed to finding new solutions to overcome biological barriers. Learn how our dedicated work is advancing the development of a delivery platform to improve the transport of many drug candidates for brain diseases that are not able to cross the blood-brain barrier unaided. Click the link to read more about our story, her story and the future of our technology! ➡️ https://lnkd.in/e6GsTanE Thank you, Life Science Nation, for highlighting our project and giving it visibility. #Innovation #Biotech #Leadership #WomenInScience #Healthcare #medicinesbeyondbarriers

As summer unfolds in all its glory, it's time for a well-deserved break! 🌞 The Gate2Brain team is taking this opportunity to relax, recharge, and soak in the season’s warmth. We’re hitting pause to unwind and return with fresh vigor. Here's to a summer filled with joy and unforgettable moments! ☀️🏝️ We can't wait to come back rejuvenated, ready to tackle new challenges and continue bringing medicines beyond barriers! With Summer vibes,   Gate2Brain’s Team **Image generated with AI

📅 🧠To mark #WorldBrainDay, AseBio - Asociación Española de Bioempresas, which represents the interests of companies, associations, foundations, universities, and technology and research centers in the biotechnology sector in Spain for 25 years, has dedicated a feature to Gate2Brain's technology. In this feature, our CEO and CSO, Meritxell Teixido , examines the scientific and technological advancements that bring us closer to more effective treatments and potential cures for brain tumors, emphasizing one of the most critical areas needing attention and development: brain tumors, particularly those affecting children, such as diffuse intrinsic pontine glioma (DIPG). This type of tumor presents unique challenges due to its location in the brainstem and the presence of the intact blood-brain barrier (BBB), which hinders the administration of effective treatments. In this context, Gate2Brain's technology emerges as a ray of hope, with innovations that promise to transform the treatment landscape for these tumors. Read the full article to learn more about the challenges of DIPG, the potential impact of Gate2Brain technology, and the path ahead. English version 👉 https://lnkd.in/dYehY8bH Spanish version 👉 https://lnkd.in/dNmpu8KZ Thank you, AseBio - Asociación Española de Bioempresas, for highlighting the sector innovations and addressing our needs through Voz Biotech. Your support helps us strengthen and transform our system, ensuring we stay impactful and relevant. Let us continue to support and invest in research on brain diseases, as every step forward brings us closer to new treatments and better outcomes for those affected. Gate2Brain bringing Medicines Beyond Barriers. #WorldBrainDay #MedicinesBeyondBarriers

Recently, a new member joined our team. We're so grateful to have such an awesome crew!! 👋 It’s a pleasure to introduce one of our new team members, Alejandro Sosnik, Gate2Brain’s new Nanotech Advisor. Alejandro Sosnik has more than 30 years of research experience. He specializes in biomaterials for drug delivery and tissue engineering, focusing on polymer and macromolecular chemistry and drug and polymer self-assembly. His work involves designing nanoparticles for drug encapsulation and developing nanobiomaterials for cancer therapy. Currently at Technion-Israel Institute of Technology, he leads projects involving the synthesis, characterization and application of polymeric and hybrid ceramic/polymeric nanoparticles and their assessment in in vitro and in vivo disease models. Over the last years, he introduced a novel family of hybrid nano-sonosensitizers for the actively targeted sonodynamic therapy of solid tumors. ✅At Gate2Brain, his responsibility encompasses giving advice on the physicochemical and structural characterization of G2B-002, a novel anticancer nanoformulation for the therapy of brain tumors, toward its translation into the clinic. Alejandro was actively involved in the design and development of this actively targeted nanoformulation produced by a unique self-assembly approach. ✅ What are his hobbies and interests? Swimming is almost like breathing for him. He aims to swim every day when he’s not traveling, which is another one of his passions, especially with his wife and kids.  He particularly enjoys traveling in the Far East ✅ What does he like about the Gate2Brain project? One of his professional dreams since his undergraduate Pharmacy studies at the University of Buenos Aires has been to bring innovative solutions to treat human disease and since he started an independent scientific career has devoted many efforts to overcome hurdles in the therapy of pediatric disease. The Gate2Brain project is the conjunction of all these goals, he believes that the Gate2Brain platform can lead to a breakthrough in the treatment of brain tumors and is extremely motivated to actively participating and contributing to its success.    ✅ A surprising fact about him! He loves music, especially Rock & Pop. As a teenager, he used to attend every concert in his hometown, Buenos Aires. Some of the most memorable ones include The Cure, Sting, Peter Gabriel, Eric Clapton, Paul McCartney, Bruce Springsteen, Elton John, INXS, Prince, Joe Cocker, Roxette, and Paul Simon. Lately, he traveled with his family to the Coldplay concert at the Olympic Stadium in Athens. 🌱Great assets have joined Gate2Brain’s journey! Alejandro, welcome to the Gate2Brain family! #startup #science #research #biotech #gate2brainfamily #medicinesbeyondbarriers

We are thrilled to announce that our CEO, Meritxell Teixido, has been appointed as a new member of the Entrepreneurial Advisory Board of The Peptide Drug Hunting Consortium. As an Advisory Board member, Meritxell aims to contribute to the Consortium’s initiatives that drive the future R&D and clinical success of peptide drugs worldwide and support the strategic scientific and business needs of peptide drug hunters. Meritxell's words: "I am deeply grateful to the global peptide community that has seen me grow as both a scientist and an entrepreneur." We look forward to seeing the positive impact of all the Advisory Board members to the Consortium and the peptide drug development field. Knowledge and science beyond barriers!!! #peptides #science #enterpreneurship

As we mark the fourth anniversary of Gate2Brain, we reflect on an incredible journey filled with challenges, opportunities, and remarkable achievements. Our mission to improve patients' quality of life by providing superior drug transport efficacy with reduced side effects has driven us to innovate and persevere. Over the past four years, we’ve faced numerous challenges, but each obstacle has only strengthened our resolve. These experiences have shaped us into a more resilient and dynamic team, always pushing the boundaries of what’s possible. A heartfelt thank you to our dedicated team and collaborators. Your unwavering passion, expertise, and hard work are the pillars of our success. As we look ahead, we are filled with optimism and determination. The journey is far from over, and we are excited to continue pushing the frontiers of science and innovation. Here's to many more years of improving our technology to bring medicines beyond barriers. Thank you for being a part of our story. The best is yet to come! #Gate2Brain #Innovation #Healthcare #Anniversary #Teamwork #Journey #Future #QualityOfLife #MedicinesBeyondBarriers

Today, we are thrilled to celebrate a milestone for our Preclinical & Clinical Project Manager, Helena Castillo Ecija PhD, MBA. She has successfully completed the Scientific Project Management Course organized by Barcelona Institute of Science and Technology (BIST) led by Iolanda Marchueta. Helena stated, "This intensive course provided me with invaluable insights and practical experience, fostering collaboration among #BISTCommunity professionals." The key learnings from the course included: •⁠ ⁠Proper Planning Prevents Poor Performance •⁠ ⁠Effectively Managing Risks is Crucial •⁠ ⁠Recognize and Celebrate Each Milestone •⁠ ⁠Supervise the Progress of the Project Helena was recognized as the winner on the final day pitch competition🏆, where participants presented their projects to a jury, showcasing the methodology and tools they had mastered. She also tied for first place with another team in front of the audience. Congratulations, Helena! We are confident that the knowledge and skills you have gained will significantly benefit both you and Gate2Brain. Thank you, Helena, for your dedication. And thank you, Barcelona Institute of Science and Technology (BIST) and Iolanda Marchueta, for organizing this course and sharing your expertise. Let's continue to embrace new challenges, learn continuously, and celebrate our achievements together! #ProjectManagement #ScientificProjectManagement #TeamWork #Leadership #BISTCommunity #BIST #Gate2Brain #KnowledgeBeyondBarriers